PMA device
EVO Visian Implantable Collamer Lens for Myopia (VICMO)
STAAR Surgical Company · Lens, Intraocular, Phakic (MTA, Class III) · First FDA decision Oct 1, 2024, newest Mar 5, 2025Nearsightedness and refractive error
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
3
Naming "EVO Visian"
MAUDE reports
3,601
Brand "EVO Visian", since 2015
PubMed studies
18
Mentioning "EVO Visian"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing EVO Visian Implantable Collamer Lens for Myopia (VICMO)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- EVO Visian Implantable Collamer Lens for Myopia (VICMO), EVO Visian Toric Implantable Collamer Lens for Myopia (VTICMO),PMA supplement
P030016-S047 · Decided Mar 5, 2025 · 176 days after receipt · Normal 180 Day Track No User Fee
Device type: Lens, intraocular, phakic (MTA) · Ophthalmology
- EVO Visian Implantable Collamer Lens for Myopia (VICMO), EVO Visian Toric Implantable Collamer Lens for Myopia (VTICMO),PMA supplement
P030016-S045 · Decided Oct 1, 2024 · 172 days after receipt · Normal 180 Day Track No User Fee
Device type: Lens, intraocular, phakic (MTA) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "EVO Visian", any status and sponsor, newest update first.
Staar Surgical CompanyNot on our public-company list
NCT03499821 · 41 participants · Start Mar 20, 2018 · Primary completion Jul 9, 2019
Device: EDOF ICL · For: Presbyopia
Sites: Antwerp, Belgium; Oviedo, Spain; Almería, Spain · 6 sites in all
Staar Surgical CompanyNot on our public-company list
NCT04283149 · 327 participants · Start Jan 30, 2020 · Primary completion Apr 5, 2021
Device: EVO/EVO+ Visian ICL · For: Myopia; Myopic Astigmatism
Sites: Phoenix, Arizona; Honolulu, Hawaii; Indianapolis, Indiana · 14 sites in all
Staar Surgical CompanyNot on our public-company list
NCT07291739 · 47 participants · Start Aug 22, 2022 · Primary completion Oct 18, 2024
Device: Implantable Collamer Lens (ICL) · For: Myopia; Hyperopia; Astigmatism and 1 more
Sites: Makati City, Philippines
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "EVO Visian", and for the whole product code for context.
This brand
3,601 reports: 2 malfunction, 3,599 injury, 0 death
Whole product code MTA
18,526 reports: 3,641 malfunction, 14,883 injury, 2 death
Newest reports for this brand
2023826-2026-02047 · Received Oct 30, 2026 · Event dated May 12, 2026
Device type: Phakic Toric Intraocular Lens (QCB)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Blurred Vision
2023826-2026-02051 · Received Oct 30, 2026 · Event dated Sep 30, 2026
Device type: Phakic Toric Intraocular Lens (QCB)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Visual Disturbances
2023826-2026-02052 · Received Oct 30, 2026 · Event dated Sep 30, 2026
Device type: Phakic Toric Intraocular Lens (QCB)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Visual Disturbances
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1480-2026 · Started Jan 21, 2026 · Posted by FDA Mar 2, 2026
Reason given: Toric Implantable Collamer for correction/reduction of myopia in phakic eyes with astigmatism were labeled as 12.1 mm length but are 12.6 mm length lenses, so there is the potential for excessive vault, which may cause: Significant reduction of irido-corneal angles, Significant shallowing of anterior chamber, Patient...
Cause as FDA categorized it: Process control · Device type: Phakic Toric Intraocular Lens (QCB)
Z-0464-2024 · Started Sep 29, 2023 · Posted by FDA Dec 1, 2023
Reason given: Their is a potential that intraocular implant devices may not meet specifications.
Cause as FDA categorized it: Software design (manufacturing process) · Device type: Lens, Intraocular, Phakic (MTA)
Z-0465-2024 · Started Sep 29, 2023 · Posted by FDA Dec 1, 2023
Reason given: Their is a potential that intraocular implant devices may not meet specifications.
Cause as FDA categorized it: Software design (manufacturing process) · Device type: Lens, Intraocular, Phakic (MTA)
5 more recall records with a free account
Published research
The most relevant PubMed records for "EVO Visian"[tiab]. The summary above synthesizes these.
- EVO/EVO+ Visian Implantable Collamer Lenses for the correction of myopia and myopia with astigmatism.
Martínez-Plaza E, López-de la Rosa A, López-Miguel A, et al. · Expert Rev Med Devices · 2023Review
- Accuracy of Reported Sizes of the EVO/EVO+ Visian Implantable Collamer® Lenses.
Hirabayashi M, Virdi G, Nasser T, et al. · Cureus · 2025
- Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life.
Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. · Am J Ophthalmol · 2021Research Support, Non-U.S. Gov't
- Assessment of the iridocorneal angle pigmentation and structures after the implantation of EVO+ߙVisian Implantable Collamer Lens.
Martínez-Plaza E, López-de la Rosa A, Ossa-Calderon C, et al. · Int Ophthalmol · 2023
- Intraocular Implantable Collamer Lens with a Central Hole Implantation: Safety, Efficacy, and Patient Outcomes.
Wannapanich T, Kasetsuwan N, Reinprayoon U · Clin Ophthalmol · 2023Review
- Characterization of vault with two models of posterior chamber phakic intraocular lenses.
Paredes B, Mora de Oñate J, Martín Sánchez D, et al. · J Cataract Refract Surg · 2024Comparative Study
- Phakic intraocular lenses: an update and review for the treatment of myopia and myopic astigmatism in the United States.
Moshirfar M, Webster CR, Ronquillo YC · Curr Opin Ophthalmol · 2022Meta-Analysis, Review
- Inter-eye and postoperative prediction of vault after implantation of EVOߙ+ߙVisian phakic implantable collamer lens.
Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. · Int Ophthalmol · 2023
- Mesopic pupil indices as potential risk factors for glare disability after intraocular implantable collamer lens implantation: prospective study.
Xiong J, Xu J, Zhou M, et al. · J Cataract Refract Surg · 2024Observational Study
- Changes of ocular biometry in eyes with posterior chamber phakic intraocular lens implantation.
Kayhan B, Coskunseven E · J Fr Ophtalmol · 2022Observational Study
- Comparison of Visual and Refractive Outcome between Two Methods of Corneal Marking for Toric Implantable Collamer Lenses (TICL) in Phakic Eyes.
Feldhaus L, Mayer WJ, Dirisamer M, et al. · Curr Eye Res · 2023
- Severe intraocular pressure rise after implantable collamer lens implantation.
Moshirfar M, Moin KA, Pandya S, et al. · J Cataract Refract Surg · 2024Case Reports
Other devices of this type
Also filed under product code MTA.
- Visian Icl (Implantable Collamer Lens)STAAR Surgical Company · PMA 2025
- EVO/EVO+ VISIAN® Implantable Collamer® LensesSTAAR Surgical Company · PMA 2022
- Visian Toric ICL (Implantable Collamer Lens)STAAR Surgical Company · PMA 2019
- ARTISAN/Verisyse Myopia Phakic Intraocular Lens (IOL)Ophtec BV · PMA 2018
- Staar Surgical Implantable Collamer Lens (Vision Icl)STAAR Surgical Company · PMA 2017
- Artisan MyopiaOphtec BV · PMA 2024
- EVO/EVO+VISIAN Implantable Collamer LensSTAAR Surgical Company · PMA 2022
- Visian Implantable Collamer LensesSTAAR Surgical Company · PMA 2014
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.